From: Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists’ recommendations for active treatment or active surveillance: a randomized clinical utility trial
Case Type
Standard
Standard + Protein-based Assay
A
Evidence-based treatmenta
Assay confirms treatment
B
Assay recommends switch (e.g., AS to AT)
C
Ambiguous treatment course
Assay resolve ambiguity